Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 2 | AVENIR LIFECARE PHARMA PRIVATE LIMITED | Awarded | 1 | ₹4.4 L |
| 2 | Schedule 3 | Not yet disclosed by govt. | Awarded | 1 | - |
| 3 | Schedule 4 | AARAV PHARMACEUTICALS | Awarded | 1 | ₹13,284 |
| 4 | Schedule 5 | AAYANSH MEDICOS | Awarded | 1 | ₹36,890.40 |
| 5 | Schedule 6 | Not yet disclosed by govt. | Awarded | 1 | - |
Tender Value
₹76.2 L
EMD Value
Exempted
Closing Date
15 Jun 2024, 9:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Inj
6409844
GEM/2024/B/4950248
Two Packet Bid
Inj Factor Vlll 2000IU,Darolutamide 300mg Tab,Tenofovir 300 mg plus Lamivudine 300 mg plus Dolutegr
30 days
Telangana; Hyderabad
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹3
80%
Exempted
15 Jun 2024
25 May 2024
15 Jun 2024
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Inj Factor Vlll 2000IU | Inj Factor Vlll 2000IU | 6 | number | Hyderabad | 30 |
| 2 | Darolutamide 300mg Tab | Darolutamide 300mg Tab | 180 | number | Hyderabad | 30 |
| 3 | Tenofovir 300 mg plus Lamivudine 300 mg plus Dolutegravir 50 mg Tab | Tenofovir 300 mg plus Lamivudine 300 mg plus Dolutegravir 50 mg Tab | 3,390 | number | Hyderabad | 30 |
| 4 | Tab Bictegravir 50 mg plus Emtricitabine 200 mg plus Tenofovir alfanamide 25 mg | Tab Bictegravir 50 mg plus Emtricitabine 200 mg plus Tenofovir alfanamide 25 mg | 180 | number | Hyderabad | 30 |
| 5 | Tab Bempeboic acid 180 mg | Tab Bempeboic acid 180 mg | 2,280 | number | Hyderabad | 30 |
| 6 | Tab Nilotinib 200 mg | Tab Nilotinib 200 mg | 1,620 | number | Hyderabad | 30 |
| 7 | Resp Sol Mesna 200 mg | Resp Sol Mesna 200 mg | 180 | number | Hyderabad | 30 |
| 8 | LEVOSALBUTAMOL 0 point 63 RESPULES | LEVOSALBUTAMOL 0 point 63 RESPULES | 900 | number | Hyderabad | 30 |
| 9 | Inj Benralizumab 30 mg PFS | Inj Benralizumab 30 mg PFS | 18 | vial | Hyderabad | 30 |
| 10 | tab pirfenidone 801 mg | tab pirfenidone 801 mg | 900 | number | Hyderabad | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6409844.pdf
GEM_BID
demand_2024-05-16-14-32-36_a2f4a8b0702962e2a7e0f08543747c52.pdf
BOQ
dglp_aon_2_file_1_2024-05-16-14-32-36_372818295b131f063919925d3b238521.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .